| 000 | 01499 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517101915.0 | ||
| 264 | 0 | _c20170814 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/leu.2016.138 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNazha, A | |
| 245 | 0 | 0 |
_aIncorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes. _h[electronic resource] |
| 260 |
_bLeukemia _c11 2016 |
||
| 300 |
_a2214-2220 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xdiagnosis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aNarkhede, M | |
| 700 | 1 | _aRadivoyevitch, T | |
| 700 | 1 | _aSeastone, D J | |
| 700 | 1 | _aPatel, B J | |
| 700 | 1 | _aGerds, A T | |
| 700 | 1 | _aMukherjee, S | |
| 700 | 1 | _aKalaycio, M | |
| 700 | 1 | _aAdvani, A | |
| 700 | 1 | _aPrzychodzen, B | |
| 700 | 1 | _aCarraway, H E | |
| 700 | 1 | _aMaciejewski, J P | |
| 700 | 1 | _aSekeres, M A | |
| 773 | 0 |
_tLeukemia _gvol. 30 _gno. 11 _gp. 2214-2220 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2016.138 _zAvailable from publisher's website |
| 999 |
_c26132282 _d26132282 |
||